To the full analysis
Merck KGaA stock: growth
MRK.DEMerck KGaA reported $23.48B in revenue for fiscal 2025, down 0.3% on the prior year, up 3.8% a year on average over up to five years.
Daily figure as of 12 Nov 2026
Revenue (Annual rate)
8.5%
per year from 2006 to 2025, per share 7.9%
Earnings (Annual rate)
5.3%
per year from 2006 to 2025, per share 4.7%
Free cash flow (Annual rate)
8.5%
per year from 2006 to 2025, per share 7.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 3.8% | 5.1% | 8.5% |
| Revenue per share | 3.8% | 5.1% | 7.9% |
| Earnings | 5.6% | 8.9% | 5.3% |
| Earnings per share | 5.6% | 8.9% | 4.7% |
| Free cash flow | 4.2% | 4.6% | 8.5% |
| Free cash flow per share | 4.2% | 4.6% | 7.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $4.96B | $1.09B | $558.46M |
| 2007 | $7.85B | $32.49M | $906.18M |
| 2008 | $8.41B | $408.47M | $543.44M |
| 2009 | $8.62B | $407.58M | $898.39M |
| 2010 | $10.34B | $703.34M | $1.43B |
| 2011 | $11.43B | $674.86M | $918.2M |
| 2012 | $12.43B | $630.57M | $2.22B |
| 2013 | $12.35B | $1.34B | $1.9B |
| 2014 | $12.64B | $1.29B | $2.32B |
| 2015 | $14.29B | $1.24B | $1.67B |
| 2016 | $16.72B | $1.81B | $1.86B |
| 2017 | $16.15B | $2.9B | $1.54B |
| 2018 | $16.51B | $1.26B | $1.34B |
| 2019 | $17.97B | $1.47B | $2.04B |
| 2020 | $19.51B | $2.21B | $2.13B |
| 2021 | $21.91B | $3.4B | $3.56B |
| 2022 | $24.74B | $3.7B | $2.73B |
| 2023 | $23.36B | $3.14B | $1.96B |
| 2024 | $23.54B | $3.09B | $2.67B |
| 2025 | $23.48B | $2.9B | $2.61B |
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 24 Apr 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.